Side-by-side financials for CRVO and ABBV. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRVO | ABBV |
|---|---|---|
| Market cap | - | $397.44 B |
| US-listed rank | - | #28 |
| Revenue (latest FY) | $4.01M | $61.16B |
| Net income (latest FY) | -$26.97M | $4.23B |
| Net margin | -673.2% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 962 | 1,008 |
In their latest fiscal years, CervoMed Inc. reported $4.01M in revenue while AbbVie Inc. reported $61.16B.
Full pages: CervoMed Inc. and AbbVie Inc., or browse the full rankings.